I spoke with neuroscientists from an Incheon, Korea-based startup that's looking to minimize the symptoms of epilepsy or Parkinson's disease.
LAS VEGAS, Jan. 7, 2026 /PRNewswire/ -- LumiMind, a next-generation neurotechnology company pioneering non-invasive, real-time neural modulation, will showcase breakthrough brain--computer interface ...
As we enter 2026, there are two distinct technologies used by clinicians to interact with the brain: Brain-Computer Interfaces and Neuromodulation.
Toddlers who spend hours in front of a screen are more likely to suffer anxiety issues as teenagers, warns new research. Long ...
Could a future exist where the brain and artificial intelligence systems communicate as effortlessly as a smartphone connecting to Wi-Fi? This may sound like science fiction, but researchers are ...
Scientists working to enhance brain-computer interface (BCI) technology—which allows people to control devices with their thoughts—have found they can improve the performance of electrodes implanted ...
Please provide your email address to receive an email when new articles are posted on . The Stentrode brain-computer interface offers a non-invasive, nonsurgical solution for paralysis. Additional ...
Every four years at the Cybathlon, teams of researchers and technology “pilots” compete to see whose brain-computer interface holds the most promise. Owen Collumb, a Cybathlon race pilot who has been ...
Synchron has reeled in another $200 million in a series D round—cash the company said it will use to expand operations and accelerate commercialization of its nonsurgical brain-computer interface (BCI ...
New York-based Synchron, a brain-computer interface (BCI) company, has raised $200 million in Series D funding, bringing its total raise to $345 million. Double Point Ventures led the round, with ...
NEW YORK--(BUSINESS WIRE)--Synchron, a leader in non-surgical brain-computer interface (BCI) technology, announced today it has raised a $200 million Series D financing round. The funding will ...
Synchron, a New York, NY-based manufacturer of non-surgical brain-computer interface technology, said it has raised a $200 million series D round. The funds are expected to accelerate ...